Pfizer to appeal invalidated Celebrex patent By: Pittsburgh Business Times via Business Journals March 12, 2014 at 15:00 PM EDT Pharmaceutical giant Pfizer Inc. said Wednesday afternoon it will appeal a ruling that invalidated a key patent extension related to Celebrex... Read More >> Related Stocks: Pfizer Teva Pharmaceutical Industries ADR